Skip to main content

Table 5 Changes in the incremental cost-effectiveness ratio (ICER) with changes in the prevalence of pulmonary NTM infections

From: Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria

  Smear negative all Smear negative HIV+
Prevalence NTM TB+ ICER (US $) TB+ ICER (US $)
35% 99 19.45 36 12.7
30% 93 20.70 34 13.5
25% 88 21.90 31 14.8
20% 82 23.50 29 15.8
15% 76 25.36 27 17.0
10% 70 27.54 25 18.3
5% 64 30.12 22 20.8
  1. NTM Non tuberculosis mycobacteria, TB+ smear negative cases with chest-x-ray signs consistent with tuberculosis.